Ignite Creation Date:
2025-12-24 @ 4:39 PM
Ignite Modification Date:
2026-01-17 @ 3:23 AM
Study NCT ID:
NCT01497366
Status:
COMPLETED
Last Update Posted:
2014-04-02
First Post:
2011-12-19
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase 3 Study of Sofosbuvir and Ribavirin
Sponsor:
Gilead Sciences
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-12
Start Date Type:
None
Primary Completion Date:
2013-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-04
Completion Date Type:
ACTUAL
First Submit Date:
2011-12-19
First Submit QC Date:
None
Study First Post Date:
2011-12-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-01-15
Results First Submit QC Date:
None
Results First Post Date:
2014-04-02
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2013-12-06
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2014-03-04
Last Update Post Date:
2014-04-02
Last Update Post Date Type:
ESTIMATED